Targeted therapy of B cell malignances with CAR-T cells of defined composition

Christopher S Carlson

Impact of primary tumor development stage on prognosis and outcome in B-ALL

Leukaemia

Pediatric oncology or childhood cancer

Peng Huang

ROS, Redox Regulation and Novel Targets for Cancer Therapy

Leukaemia

Peter D Cole

Markers of Cognitive Decline During Treatment for Childhood ALL

Leukaemia

Arash Ash Alizadeh

Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Timothy Jensen Henrich

Impact of Chemotherapy and Stem Cell Transplant on HIV-1 Reservoir Dynamics

Leukaemia

Hematology and hematologic malignancies

Nathanael S Gray

MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Franziska Michor

Evolution and Treatment Response of Brain, Breast, and Hematologic Malignancies

Leukaemia Non-Hodgkin lymphoma

Christopher S Carlson

Monitoring disease progression in follicular lymphoma with next-gen sequencing

Non-Hodgkin lymphoma

Pathology

Talya Salz

Do cardiovascular risk factors modify the cardiotoxicity of lymphoma treatments?

Non-Hodgkin lymphoma